Internal Medicine · Rego Park, NY
NPI
1447296421
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
9830 67th Ave Ste Gg
Rego Park, NY, 11374
Phone (718) 896-7777
Groups this clinician bills Medicare through
Medicare paid, 2024
$458K
8,077 services
Medicare patients, 2024
404
Average age 78
Drug cost, 2024
$3.8M
24,524 prescriptions
Company payments, 2025
$3,082
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rita Goldvug was code 99490 (chronic, principal, and transitional care management), 2,292 times for 226 patients. In total Rita Goldvug billed 8,077 services in 50 codes, and Medicare paid $458K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-03-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 2,292 | 226 | $56.66 | $130K |
| 99213 Office E&M - Established | Office | 1,538 | 345 | $81.64 | $126K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 629 | 196 | $43.50 | $27K |
| 36415 Venipuncture Blood Collection | Office | 600 | 322 | $8.65 | $5,190 |
| 99214 Office E&M - Established | Office | 450 | 247 | $108.07 | $49K |
| 93000 Electrocardiogram | Office | 243 | 199 | $12.99 | $3,157 |
| 99442 Telephone Services | Office | 227 | 123 | $81.06 | $18K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 227 | 227 | $157.27 | $36K |
| 96372 Injection Administration | Office | 186 | 57 | $13.31 | $2,477 |
| 96365 Intravenous Infusion, Hydration | Office | 178 | 72 | $61.38 | $11K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 178 | 178 | $23.31 | $4,149 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 163 | 67 | $0.51 | $82.8 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 159 | 104 | $38.44 | $6,111 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 110 | 88 | $15.48 | $1,703 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 104 | 38 | $0.91 | $94.36 |
By year: 2022 $480K for 8,675 services; 2023 $475K for 8,445 services; 2024 $458K for 8,077 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 600 | 322 | $8.65 | $5,190 |
| 82947 Clinical Chemistry | 68 | 47 | $3.85 | $262 |
| 87426 Immunoassay | 62 | 52 | $34.62 | $2,146 |
| 87804 Immunoassay | 58 | 25 | $16.22 | $941 |
Medicare prescription drug claims, 2024
In 2024, the drug Rita Goldvug prescribed most often to Medicare patients was Rosuvastatin Calcium, with 1,207 prescriptions and refills. In total Rita Goldvug wrote 24,524 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 1,207 | 1,749 | 208 | $7,750 |
| Famotidine Generic | 1,068 | 1,219 | 188 | $7,675 |
| Amlodipine Besylate Generic | 1,068 | 1,468 | 182 | $2,302 |
| Metoprolol Succinate Generic | 1,042 | 1,439 | 163 | $7,502 |
| Losartan Potassium Generic | 935 | 1,290 | 153 | $3,907 |
| Metformin Hcl Generic | 777 | 1,065 | 122 | $19K |
| Atorvastatin Calcium Generic | 638 | 906 | 98 | $2,717 |
| Escitalopram Oxalate Generic | 450 | 597 | 78 | $1,924 |
| Levothyroxine Sodium Generic | 431 | 601 | 64 | $2,488 |
| Gabapentin Generic | 400 | 488 | 80 | $2,135 |
| Vascepa Icosapent Ethyl | 386 | 392 | 47 | $130K |
| Linzess Linaclotide | 376 | 415 | 54 | $209K |
| Ezetimibe Generic | 374 | 486 | 65 | $2,959 |
| Januvia Sitagliptin Phosphate | 362 | 412 | 47 | $218K |
| Clopidogrel Clopidogrel Bisulfate | 328 | 433 | 48 | $1,186 |
Brand drugs: 5,961 claims; generic drugs: 18,217 claims; opioid claims: 37.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rita Goldvug $3,082 ($3,082 in general payments such as food, travel and fees) from 22 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $641.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 22 | $641 |
| Amgen Inc. AMGN | 15 | $478 |
| Abbvie Inc. ABBV | 19 | $454 |
| Pfizer Inc. PFE | 13 | $379 |
| Novo Nordisk Inc NVO | 7 | $184 |
| Aimmune Therapeutics, Inc. | 7 | $170 |
| Exact Sciences Corporation EXAS | 4 | $125 |
| Astellas Pharma US Inc 4503.T | 5 | $125 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 5 | $93.97 |
| Scilex Pharmaceuticals Inc. | 4 | $76.94 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.